1. Home
  2. PPHC vs AVIR Comparison

PPHC vs AVIR Comparison

Compare PPHC & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PPHC

Public Policy Holding Company Inc. Common Stock

N/A

Current Price

$12.76

Market Cap

307.9M

Sector

N/A

ML Signal

N/A

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$6.06

Market Cap

318.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPHC
AVIR
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.9M
318.0M
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
PPHC
AVIR
Price
$12.76
$6.06
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
88.5K
564.6K
Earning Date
N/A
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.00
EPS
N/A
N/A
Revenue
N/A
$351,367,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.25
$2.46
52 Week High
$14.50
$6.45

Technical Indicators

Market Signals
Indicator
PPHC
AVIR
Relative Strength Index (RSI) 54.91 77.25
Support Level $11.50 $3.33
Resistance Level $14.50 $6.45
Average True Range (ATR) 0.74 0.32
MACD 0.06 0.06
Stochastic Oscillator 48.31 81.98

Price Performance

Historical Comparison
PPHC
AVIR

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: